Endonucleases: tools to correct the dystrophin gene

Area of Science:

• Molecular Biology
• Genetics
• Biotechnology

Background:

• Engineered endonucleases induce DNA double-strand breaks (DSBs) at specific sites.
• Nonhomologous end-joining repair of DSBs results in insertions/deletions (INDELs).
• This study investigates INDELs generated by meganucleases and zinc finger nucleases in human genes.

Purpose of the Study:

• To characterize and quantify INDELs produced by specific endonucleases.
• To evaluate the efficiency of engineered nucleases in human cells.
• To assess the potential therapeutic applications of endonuclease-induced gene editing.

Main Methods:

• Utilized meganucleases (MGNs) and zinc finger nucleases (ZFNs) to target RAG1 and dystrophin genes.
• Analyzed INDELs via Surveyor nuclease assay, bacterial cloning, and deep sequencing.
• Conducted experiments in human 293T cells, myoblasts, and myotubes.

Main Results:

• Endonucleases generated INDELs of varying sizes with distinct size distribution peaks.
• INDEL patterns differed between MGNs and ZFNs in different cell types.
• INDELs produced could alter gene reading frames, and their frequency increased with re-exposure to endonucleases.

Conclusions:

• Engineered endonucleases can restore gene reading frames, delete nonsense codons, and knockout genes.
• These nucleases offer potential therapeutic strategies for genetic diseases like Duchenne muscular dystrophy.
• Gene editing via endonucleases presents a promising approach for treating hereditary disorders caused by frame shift or nonsense mutations.